Michel BoussinesqJoseph KamgnoSébastien D. S. PionJacques Gardon2026-03-222026-03-22200610.1016/j.pt.2006.04.006https://doi.org/10.1016/j.pt.2006.04.006https://andeanlibrary.org/handle/123456789/86838Citaciones: 34enIvermectinOnchocerciasisConfusionAdverse effectWonderMedicineAntiparasitic agentIntensive care medicinePsychiatryPsychologyWhat are the mechanisms associated with post-ivermectin serious adverse events?letter